Lyle J Arnold, Biocept's SR VP of R&D and CSO, recently acquired 50,000 shares of the company. The buys took place at $0.00 per share (and therefore, likely the result of option or restricted share grants), on July 06, 2016. Arnold now owns 60,714 shares of the company. Arnold operates out of San Diego, CA. Some additional info was provided as follows:
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Biocept makes a similar move, sign up!
Other recent filings from the company include the following:
Biocept Just Filed Its Quarterly Report:
10. Net Loss per Co... - May 15, 2017
Securities to be offered to employees in employee benefit plans - May 15, 2017
Biocept Reports First Quarter 2017 Financial Results - May 11, 2017
Biocept: With Respect To Restricted Awards, The Restricted Period Sha - May 5, 2017